Ariad Pharmaceuticals Inc $5.77

up +0.01


19/9/2014 04:00 PM  |  NASDAQ : ARIA  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ARIA Trend Analysis - it has underperformed the S&P 500 by 90%

Partner Headlines

  1. GNC, Southern Copper And Others Insiders Have Been Buying

    Benzinga
  2. ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel

    Benzinga
  3. Morning Market Movers

    Benzinga
  4. Benzinga's Top #PreMarket Gainers

    Benzinga
  5. Benzinga's M&A Chatter for Wednesday July 23, 2014

    Benzinga
  6. ARIAD Announces Continuation of Iclusig Review Related to Article 20 Procedure ...

    Benzinga
  7. 3 Biotech Stocks Backed By Big Money

    Benzinga
  8. Morning Market Losers

    Benzinga
  9. Benzinga's Top #PreMarket Losers

    Benzinga
  10. Earnings Scheduled For May 7, 2014

    Benzinga
  11. Morning Market Movers

    Benzinga
  12. Benzinga's Top #PreMarket Gainers

    Benzinga
  13. Market Wrap For March 28: Markets Still Positive Despite Giving Up Early ...

    Benzinga
  14. Mid-Day Market Update: Restoration Hardware Surges On Earnings; Endocyte ...

    Benzinga
  15. Mid-Morning Market Update: Markets Open Higher; BlackBerry Reports Smaller-Than-Expected ...

    Benzinga
  16. Benzinga's Top #PreMarket Gainers

    Benzinga
  17. Morning Market Movers

    Benzinga
  18. Top Trending Tickers On StockTwits For March 14

    Benzinga
  19. Benzinga's Top Downgrades

    Benzinga
  20. Market Wrap For February 25: Markets End The Day Relatively Flat

    Benzinga
  21. Top Trending Tickers On StockTwits For February 25

    Benzinga
  22. Earnings Scheduled For February 25, 2014

    Benzinga
  23. You Can No Longer Ignore Biotech

    GuruFocus
  24. Credit Suisse Reports Ariad's Iclusig is 'Essential Drug'

    Benzinga
  25. Tug Of War In Ariad Pharmaceuticals

    Benzinga
  26. Benzinga's M&A Chatter for Monday January 27, 2014

    Benzinga
  27. Top Trending Tickers On StockTwits For January 27

    Benzinga
  28. Market Wrap For January 24: Fear Is Back In The Markets

    Benzinga
  29. Ariad Shares Continue to Surge Amidst Buyout Rumors

    Benzinga
  30. Ariad Pharnaceuticals Continues To Rally

    Benzinga
  31. Mid-Afternoon Market Update: Markets Get Hammered on China Fears as Microsoft ...

    Benzinga
  32. Top Trending Tickers On StockTwits For January 23

    Benzinga
  33. Benzinga's Top #PreMarket Gainers

    Benzinga
  34. Benzinga's M&A Chatter for Wednesday January 22, 2014

    Benzinga
  35. Market Wrap For January 17: Stocks Finish Week With Mixed Results

    Benzinga
  36. Top Trending Tickers On StockTwits For January 17

    Benzinga
  37. Benzinga's Top #PreMarket Gainers

    Benzinga
  38. Benzinga's Top #PreMarket Losers

    Benzinga
  39. UPDATE: JMP Securities Reiterates Coverage on ARIAD Pharmaceuticals, Sees ...

    Benzinga
  40. Market Wrap For January 6: Busy Day For Analysts Upgrades and Downgrades

    Benzinga
  41. UPDATE: Ariad Pharmaceuticals Downgraded by Citigroup

    Benzinga
  42. Benzinga's Top #PreMarket Losers

    Benzinga
  43. Benzinga's Top Downgrades

    Benzinga
  44. Market Wrap For January 2: Markets Begin 2014 on Negative Note

    Benzinga
  45. Mid-Afternoon Market Update: Markets Look to Close Red as Solar Stocks ...

    Benzinga
  46. Mid-Day Market Update: ANN Surges On Analyst Upgrade; DryShips Shares Decline

    Benzinga
  47. Mid-Morning Market Update: Markets Tumble; Fiat To Acquire Rest Of Chrysler

    Benzinga
  48. Benzinga's Top #PreMarket Gainers

    Benzinga
  49. ARIAD to Present at JP Morgan Healthcare Conference on Tuesday, January ...

    Benzinga
  50. Mid-Day Market Update: US Markets Turn Lower; Twitter Shares Fall On Analyst ...

    Benzinga
Trading Center